
Aurelius Health Group Review
Best for: transparent, care-inclusive compounded tirzepatide microdosing
Aurelius Health Group is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+, L-carnitine, B12, or inositol add-ons. Pricing is fully published and care-inclusive: $89 the first month, then $199/mo covering consultations, the protocol, shipping, and monitoring. Notably, the site itself acknowledges the limited trial data behind microdosing.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Aurelius Health Group
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Aurelius Health Group at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Tirzepatide
- Starting price
- $89/mo
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How we scored Aurelius Health Group
Each dimension is scored algorithmically from Aurelius Health Group’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.9/10At $89/mo, Aurelius Health Group runs about 47% below the $169 median for GLP-1 providers.
Effectiveness25%
6.7/10Aurelius Health Group offers tirzepatide, which produced the largest average weight loss of any GLP-1 in head-to-head trials.
User Experience15%
6.2/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
5.1/10Some details we couldn't independently confirm; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
4.9/10Aurelius Health Group's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
4.7/10Aurelius Health Group provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Aurelius Health Group review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: low.
What to expect when you sign up with Aurelius Health Group
We walked Aurelius Health Group’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a ~5-minute secure health questionnaire (goals, medications, medical history, prior GLP-1 experience).
- 2A physician reviews within 24 hours.
- 3Medication ships from a licensed US compounding pharmacy.
- 4Ongoing: monthly physician check-ins and unlimited secure messaging.
- Pricing shown up front on the homepage: $89 first month, then $199/month; 'cancel anytime, no hidden fees.'
- Neither labs nor a video visit is stated as required (physician review is async within 24h).
- Compounded tirzepatide microdose model.
Aurelius Health Group customer support
- Phone
- (415) 354-6875
GLP-1 medications Aurelius Health Group offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Aurelius Health Group offers
Beyond GLP-1s, Aurelius Health Group also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check Aurelius Health Group's current pricing and active discounts before you decide.
What we like
- Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
- LegitScript Certified
- Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
- Unusually candid about the limited evidence base for microdosing
Watch-outs
- Microdose-only model — sub-therapeutic doses have thinner trial evidence and likely smaller weight loss than full-dose tirzepatide
- No semaglutide or standard full-dose option
- No named compounding pharmacy partner
- No state list and no named medical director or pharmacist-in-charge
Aurelius Health Group: a microdosing bet with refreshingly honest pricing
Aurelius Health Group is one of the few compounded tirzepatide telehealth platforms that does something unusual right on its own homepage: it admits the thing it sells doesn't have much trial data behind it. Aurelius is built entirely around tirzepatide microdosing — a deliberately low-dose version of the dual GIP/GLP-1 drug, rather than the standard full-dose ladder you'd get on brand-name Mounjaro or Zepbound. If you're drawn to the idea of a gentler, lower-intensity protocol with a transparent all-in price, Aurelius is worth a look. If your main goal is maximum weight loss backed by large clinical trials, this is probably not your provider, and Aurelius is unusually upfront about why.
How the pricing actually works
This is Aurelius's strongest feature, and it's genuinely better than most compounded brands. The price is fully published, bundled, and care-inclusive. You pay $89 for the first month, then the rate steps up to a flat figure in the low two hundreds a month thereafter. There is no per-dose surcharge, no separate consult fee, and no quiet add-on for monitoring — the subscription covers the physician consultations, the full compounded protocol, the pharmacy shipment, and ongoing check-ins in one number. For comparison, the category median across the providers we track sits around $169 a month, so Aurelius's ongoing rate lands a bit above the middle of the pack once the first-month teaser ends.
The cancellation terms are equally plain: you can cancel anytime before your next billing cycle, with no hidden fees. That kind of clarity is rare enough in compounded GLP-1 marketing that it deserves credit on its own.
What you actually get: microdosed tirzepatide, plus optional extras
The core product is injectable compounded tirzepatide dosed below the standard therapeutic range — Aurelius frames it as 'dual GIP and GLP-1 receptor activation' at a microdose level. You can layer on optional extras if you want them:
- NAD+ — marketed for energy and cellular support
- L-carnitine — often paired with weight-management protocols
- Vitamin B12 — a common energy add-on
- Inositol — frequently used for metabolic and PCOS-adjacent support
Notably, there is no semaglutide option and no standard full-dose tirzepatide path. If you start at a microdose and decide you need more, Aurelius isn't structured to take you up the full clinical ladder — you'd be looking at switching providers. Worth knowing before you commit.
The real differentiator: candor about the evidence
Most compounded sellers lean hard on the impressive full-dose trial numbers and quietly let you assume they apply to whatever they're shipping. Aurelius doesn't. The site states plainly that 'large-scale RCT data at sub-therapeutic doses is limited.' That single sentence is the most honest thing on the page, and it's the right way to read this provider: microdosing has a thinner evidence base than full-dose tirzepatide, and you should expect more modest weight loss as a result. We've covered the microdosing evidence gap in our own reviews, and Aurelius's own caveat lines up with it. Treat the transparency as a green flag for the company's character — and the underlying caveat as a real limitation on what the protocol can deliver.
Trust, oversight, and what's missing
On the credentialing side, Aurelius checks some meaningful boxes. It's LegitScript Certified, runs on a HIPAA-compliant platform, and the care model includes a real clinical wrapper: an initial consultation with a board-certified MD or DO, a 24-hour prescription review, monthly physician check-ins with protocol adjustments, and secure messaging. That's a care-inclusive setup, not a prescription-only mill.
That said, our verification confidence on Aurelius is LOW — at the stronger end of low, but low. The reasons are concrete and worth your attention:
- No named compounding pharmacy. Aurelius says only that your protocol ships from 'licensed US compounding pharmacies' — it never names which one, so you can't independently check that pharmacy's record.
- No published state list. There's no clear roster of where Aurelius can legally treat patients, so you'll need to confirm your state is covered before paying.
- No named medical director or pharmacist-in-charge. The consults are described as MD/DO-led, but no individual clinical leader is disclosed.
- No legal entity or LegitScript ID number captured. The certification seal is shown, but the supporting identifiers weren't disclosed at the time of review.
None of these are dealbreakers on their own, but together they mean you're trusting the brand's self-description more than you'd ideally like for a medication you inject. Our scoring methodology weighs exactly these gaps — named pharmacy, state coverage, clinical leadership — heavily for any product taken into the body.
Who it's for, and who should skip it
Consider Aurelius if you specifically want a microdosing protocol, you value a single bundled price with cancel-anytime terms, and you appreciate a company that's honest about the limits of what it sells. The all-in pricing and LegitScript certification make it one of the more straightforward compounded options for a low-intensity start.
Skip it if you want the strongest possible weight loss, prefer the option to climb to full therapeutic doses, want semaglutide as an alternative, or need to see a named pharmacy and a published state list before you'll hand over a card. Those are reasonable requirements, and Aurelius doesn't meet them yet.
Bottom line
Aurelius Health Group is a transparent, care-inclusive way to try compounded tirzepatide microdosing, and its honesty about the thin evidence is genuinely commendable. But honesty about a limitation doesn't erase the limitation: microdosing likely means smaller results than full-dose therapy, and the undisclosed pharmacy, missing state list, and unnamed clinical leadership keep our confidence low. If a gentle, bundled, low-commitment protocol is what you're after — and you've confirmed coverage in your state — it's a fair pick. For everyone chasing the full clinical effect, look elsewhere and verify before you buy.
Worth pricing against Embody ($79/month) and bmiMD ($99/month) before you commit — both sit close to Aurelius Health Group on cost and formulation.
The Bottom Line
Aurelius Health Group is a solid telehealth option with balanced features and pricing.
Ready to start with Aurelius Health Group?
Starting at $89/month. See current pricing and start your free consultation.
Aurelius Health Group might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider ShedRx.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Aurelius Health Group review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 7.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Aurelius Health Group's current pricing
Plans start at $89/month. Start your free consultation to check eligibility and today's price.